# Rentschler Biopharma Inc., Milford, MA – FDA Inspections

Source: https://www.keypedia.com/companies/rentschler-biopharma-inc/5ef7256a-aef2-44ce-a792-80c28829c138

> Inspection records and compliance data for Rentschler Biopharma Inc. in Milford, Massachusetts. 6 FDA inspections on record, 4 Form 483s, last inspected December 10, 2025.

---

## Details

- Name: Rentschler Biopharma Inc.
- FEI Number: 3003282293
- Address Line 1: 27 Maple St
- City: Milford
- State: Massachusetts
- Zip Code: 01757
- Country Name: United States
- Address: 27 Maple St, Milford, Massachusetts 01757, United States
- Country: United States

## Related Documents

- [483 - Rentschler Biopharma Inc. - Unknown Date](https://www.keypedia.com/records/483/rentschler-biopharma-inc/de95d6e5-df18-44ba-a408-3ae47c7a8886) — source: FDA, date: Invalid Date
- [483 - Rentschler Biopharma Inc. - Unknown Date](https://www.keypedia.com/records/483/rentschler-biopharma-inc/cea16de9-51b2-4829-9c14-fa8be6f2a0e0) — source: FDA, date: Invalid Date
- [483 - Rentschler Biopharma Inc. - 2025-12-10](https://www.keypedia.com/records/483/rentschler-biopharma-inc/d5119927-8e86-4a25-b5ee-5a23c1d26602) — source: FDA, date: December 10, 2025
- [FDA Inspection 1298478 - Rentschler Biopharma Inc. - 2025-12-10](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-inc/9a33c509-4352-4da8-a638-1145baeb9d2f) — source: FDA, date: December 10, 2025
- [483 - Rentschler Biopharma Inc. - 2025-01-17](https://www.keypedia.com/records/483/rentschler-biopharma-inc/0fe66179-4551-4180-ad52-673fd6891127) — source: FDA, date: January 17, 2025
- [EIR - Rentschler Biopharma Inc. - 2025-01-17](https://www.keypedia.com/records/eir/rentschler-biopharma-inc/6e73238f-6472-418b-a935-878b9d720dbb) — source: FDA, date: January 17, 2025
- [FDA Inspection 1259307 - Rentschler Biopharma Inc. - 2025-01-17](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-inc/fdfa31e1-e0c6-4326-a766-0c0d2116da07) — source: FDA, date: January 17, 2025
- FDA Inspection 1259307 - Rentschler Biopharma Inc. - 2025-01-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 17, 2025
- [FDA Inspection 1202865 - Rentschler Biopharma Inc. - 2023-03-24](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-inc/677dabb7-4663-4162-b23d-07be45784457) — source: FDA, date: March 24, 2023
- [483 - Rentschler Biopharma Inc. - 2023-03-22](https://www.keypedia.com/records/483/rentschler-biopharma-inc/f192f328-ac15-4dfa-b0a3-6360dc6ce911) — source: FDA, date: March 22, 2023
- [EIR - Rentschler Biopharma Inc. - 2019-12-13](https://www.keypedia.com/records/eir/rentschler-biopharma-inc/3306cffb-7bc4-435a-83a0-112dd6797561) — source: FDA, date: December 13, 2019
- FDA Inspection 1116307 - Rentschler Biopharma Inc. - 2019-12-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2019
- [483 - Rentschler Biopharma Inc. - 2018-03-26](https://www.keypedia.com/records/483/rentschler-biopharma-inc/da3845bf-1c47-4d06-8ae7-e9be7f70c57e) — source: FDA, date: March 26, 2018
- [FDA Inspection 1046134 - Rentschler Biopharma Inc. - 2018-03-26](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-inc/b20fd2e8-f6c5-4b7f-b897-73d82dc0902f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 26, 2018
- FDA Inspection 961189 - Rentschler Biopharma Inc. - 2016-02-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 23, 2016

## Related Companies

- [AGC Biologics, Inc.](https://www.keypedia.com/companies/agc-biologics-inc/9759f733-dd5f-4f2e-a516-f1b37fad39e2)
- [AGC Biologics A/S](https://www.keypedia.com/companies/agc-biologics-as/49ad0b3f-1a32-433e-b4e1-b6643981671c)
- [Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC](https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c)
- [NOVAVAX CZ](https://www.keypedia.com/companies/novavax-cz/946f94c6-3077-4879-8af9-0f52bccf0bd5)
- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff)
- [Zhejiang Peptites Biotech Co.,Ltd.](https://www.keypedia.com/companies/zhejiang-peptites-biotech-coltd/e2ec39f6-5557-4a89-bf23-65edb9d36a4e)
- [Global Calcium Pvt. Limited](https://www.keypedia.com/companies/global-calcium-pvt-limited/274540f7-e7a4-47fb-b3a0-61fb5e85d807)
- [Daiichi Sankyo Chemical Pharma Co., Ltd.](https://www.keypedia.com/companies/daiichi-sankyo-chemical-pharma-co-ltd/846f1b3f-281e-4616-ae05-902bf9bcb28c)
- [Tianjin Asymchem Pharmaceuticals Co., Ltd.](https://www.keypedia.com/companies/tianjin-asymchem-pharmaceuticals-co-ltd/1e469779-31a9-40d3-9bd8-d580e8489e7b)
- [Polpharma Biologics S.A](https://www.keypedia.com/companies/polpharma-biologics-sa/cbcf90aa-e0dc-4cd8-90ab-3389315441d8)

## Related Officers

- [Senior Consumer Safety Officer - Pharmaceutical Quality](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)
- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
- [Consumer Safety Officer](https://www.keypedia.com/people/arie-c-menachem/01bacbef-a3ae-4eb0-a56f-e8a70b67a524)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [company_representative](https://www.keypedia.com/people/katherine-niedzwiecki/251741c4-19cf-4e96-9fc7-706859602b25)
- [company_representative](https://www.keypedia.com/people/michael-henry/28620a9e-74f8-4153-8e7e-2d914be8da81)